Congestive heart failure is characterized by significant autonomic dysfunction. Development of left bundle branch block in congestive heart failure is a predictor of worse outcome. There are several lines of evidence that cardiac resynchronization therapy (CRT), by biventricular stimulation in patients with severe heart failure and left bundle branch block, improves autonomic functions which can be quantified by measuring heart rate variability. The aim of the present study was to assess the effect of CRT on autonomic functions quantified by heart rate variability and mean heart rate (HR) in patients with advanced heart failure and left bundle branch block in short and long-term follow-up. A total of 35 patients with systolic heart failure and left bundle branch block (mean-age 60 ± 11 years; 24 male and 11 female; mean left ventricular ejection fraction [EF]: 22.3 ± 3%) were enrolled. Clinical assessment and echocardiographic examination were performed at baseline and every three months. Continuous electrocardiographic monitorization by 24-hour Holter recordings was performed pre-implantation, 3 months and 2 years after implantation. Mean HR and one of the time-domain parameters of heart rate variability, standard deviation of the R-R intervals (SDNN) were measured. CRT was associated with a decrease in the mean duration of QRS, and an increase in diastolic filling time, the rate with which the left ventricular pressure rises (dP/dt), and left ventricular ejection fraction. Decrease in mean heart rate and increase in SDNN were statistically significant in the third month and second year recordings when compared to baseline recording ( p values were < 0.001 for both). In conclusion, CRT with biventricular pacing provides sustained improvement in autonomic function in patients with advanced heart failure and left bundle branch block.
In patients with heart failure, development of left bundle-branch block leads to abnormal ventricular depolarization and disturbances of the synchrony between inter-and intraventricular conduction and relaxation (Hardarson et al. 1987; Grines et al. 1989; Xiao et al. 1992; Fahy et al. 1996; Nelson et al. 2000; Saxon et al. 2000) . Disturbances of ventricular synchrony causes a shortening of diastolic filling time and effective ejection time, reduces stroke volume, prolongs mitral regurgitation and leads to an increase in global and regional wall stress (Grines et al. 1989; Xiao et al. 1992; Nelson et al. 2000) . It has been shown that development of left bundle-branch block is also an independent predictor of deteriorated functional capacity and cardiac mortality in these patients (Doval et al. 1994; Xiao et al. 1996; Aaronson et al. 1997) . Restoration of ventricular synchrony by biventricular stimulation leads to an acute and sustained improvement in left ventricular systolic function (Auricchio et al. 1999; Kass et al. 1999; Kerwin et al. 2000) , increases functional capacity, lengthens exercise duration and improves quality of life (Gras et al. 1998; Abraham et al. 2000 Abraham et al. , 2002 Zardini et al. 2000; Cazeau et al. 2001) .
Congestive heart failure is characterized by significant autonomic dysfunction consisting of sympathetic activation, parasympathetic withdrawal, and peripheral organ unresponsiveness (Grassi et al. 1995) . In recent years, cardiac autonomic dysfunction can be quantified by measuring heart rate variability (Camm et al. 1996; Urakawa and Yokoyama 2005) , which predicts cardiac mortality in patients after myocardial infarction (Camm et al. 1996) or in those with chronic heart failure (Bonaduce et al. 1999; La Rovere et al. 2003) . Basic heart rate and its modulation are primarily due to alterations in autonomic tone, parasympathetic tone slowing the heart rate and sympathetic stimulation increasing the heart rate. These heart rate fluctuations can be evaluated quantitatively by ambulatory electrocardiogram recordings and provide an evaluation of autonomic function (Akinci et al. 1993) . It has been shown that reduced time domain parameters of heart rate variability, especially reduced standard deviation of normal R-R valures (SDNN), is an independent predictor of death in patients with heart failure (Binder et al. 1992; Ponikowski et al. 1997; La Rovere et al. 2003; Nolan et al. 1998; Bonaduce et al. 1999) .
There are several lines of evidence that cardiac resynchronization therapy increases timedomain parameters of heart rate variability (Auricchio et al. 2002; Adamson et al. 2003; Alonso et al. 2003; Livanis et al. 2003) , leading to improvement in the autonomic function in these severely diseased patients. The improvement in time domain parameters of heart rate variability, especially in SDNN, results in improved prognosis Mortara et al. 2003) . Cardiac resynchronization therapy (CRT) also improves short-term prognosis and reduces hospitalization rate (Oguz et al. 2001; Bradley et al. 2003; Bristow et al. 2004 ) and mortality (Cleland et al. 2005 ). But it is not clear whether these short-term improvements in autonomic functions are persistent or not. Few studies investigated the long term effects of CRT on time-domain parameters of heart rate variability (Adamson et al. 2004; Fantoni et al. 2005) . The aim of this study is to investigate the short-and long-term effects of CRT on autonomic functions quantified by measuring SDNN and mean heart rate in patients with advanced heart failure and left bundle branch block.
METHODS
A total of 53 patients with severely symptomatic heart failure (New York Heart Association [NYHA] Class III/IV heart failure; i.e., symptoms with minimal exercise or at rest) due to left ventricular dysfunction (EF < 35%), who had complete left bundle branch block (QRS > 120 ms) and left ventricular enlargement (left ventricular end-diastolic diameter > 60 mm) had been undergone implantation of biventricular pacing system. All patients were in sinus rhythm and had no classical indication for pacemaker implantation. Patients were receiving optimized treatments, including diuretics, beta blockers and angiotensin-converting enzyme inhibitors at maximum tolerated dose. Eighteen of 53 patients with atrial fibrillation, new onset of diabetes mellitus, chronic renal failure, history of alcohol abuse, clinical evidence of autonomic neuropathy, new addition of beta blocker, ino-tropic drugs (except digitalis), amiodarone or antidepressant drugs to previous treatment regimen, inadequate Holter recordings and deaths before 2nd year control were excluded. Except for diuretics, which were frequently reduced, no further dosage adjustment of betablocking agent, angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers was usually made. No patient was crossed over to any other beta-blocking agent. Pacemakers were programmed in VDD mode with bipolar pacing/sensing and lower rate of 40 beats per minute (bpm) to allow the device to track intrinsic heart rate. Three different biventricular pacing model were used; Medtronic InSync model of 8,040 (n = 6) and 8,042 (n = 15) (Medtronic Inc., Minneapolis, MN, USA); Guidant Contac CR (n = 8) (Guidant, St. Paul, MN, USA) and Pacesetter Frontier (n = 3) (St. Jude Medical Co., Sylmar, CA, USA). Patients with effective biventricular stimulation, and atrial sensing more than 98% confirmed during pacemaker follow-up data were included and followed-up every 3 months.
Thirty-five patients (mean age 60 ± 11 years-old; 24 male, 11 female) with heart failure (NYHA III to IV, mean left ventricular EF; 22.3 ± 3%) and ventricular conduction delay (mean duration of QRS; 165.7 ± 14.7 ms) were included in the study.
The etiology of heart failure was idiopathic dilated cardiomyopathy in 14 patients and ischemic cardiomyopathy in 21 patients. Mean left ventricular (LV) enddiastolic diameter was 69.6 ± 3.8 mm. Left ventricular lead were positioned in anterolateral vein (n = 5), posterolateral vein (n = 19) and lateral vein (n = 11).
Major cardiac events were also evaluated and considered as death for any cause and hospitalization for cardiovascular reasons.
Transthoracic echocardiography
Echocardiography was performed by using HP Sonos 5500 (Hewlett-Packard; Andover, MA, USA) system equipped with a 2.5 MHz phased-array transducer at one week before and after implantation of pacemaker, then third, sixths and thereafter every 6 monhts after implantation of pacemaker. M-mode measurements of left ventricular dimensions were made according to the recommendations of the American Society of Echocardiography (Sahn et al. 1978) . LV volumes and ejection fraction were calculated by using Simpson formula. Transmitral flow was recorded using pulsed-wave Doppler from the apical four-chamber view with the sample volume placed at the mitral valve leaflet tips. The diastolic filling time (DFT) was defined as the time interval between the beginning of E wave and the end of A wave. DFT values were corrected as per heart rate by using Bazet formula (corrected DFT = measured DFT/ R-R interval). The rate with which the left ventricular pressure rises (LV dP/dt) was calculated from the CW Doppler trace with previously described "rate pressure rise" method (Bargiggia et al. 1989 ). Atrioventricular delay optimization was done by using mitral inflow method (Mehta et al. 1989; Ritter 1998; Cazeau et al. 2001) .
24-hour Holter monitorization and functional status
Twenty-four hour ambulatory ECGs were obtained with Syneflashdigital recorder (Ela Medical Inc., Minneapolis, MN, USA) at baseline, third month and second year. The 24-hour recordings were analyzed by using Syneview Holter ECG analysis software (Ela Medical Inc.). The recordings were edited to eliminate premature ectopic beats and artifacts. After elimination of artifacts and ectopic beats, Holter system gives SDNN automatically as ms. Average heart rate and SDNN during 24 hrs were recorded. Recordings with < 20 hrs analyzable data were excluded. The SDNN depends on the basic day/night difference in mean RR and to a lesser extent on short-term variations in the heart rate and may be considered a broad-band measure of autonomic balance.
Functional status according to the NYHA classification was assessed at baseline, third month and second year. Written informed consent was obtained from all patients. The study was approved by the Ethical Committe of Siyami Ersek Thoracic and Cardiovascular Surgery Center.
Statistical analyses
All data are expressed as mean ± standard deviation (S.D.). Comparisons of parameters among baseline, third month and second year were performed by multiple analysis of variance with repeated measures followed by Bonferroni test for post-hoc pairwise comparisons. Mann-Whitney's U-test was used to evaluate the differences in variables between responder and non-responder patients. SPSS software version 11.5 (SPSS Inc., Chicago, IL, USA) was used, and for all tests the level of significance was set at a value of 0.05. Table 1 summarizes the clinical and demographic characteristics of the whole population. Atrio-biventricular pacing was associated with a decrease in the mean duration of QRS, improved NYHA functional class, and an increase in diastolic filling time, left ventricular dP/dt and SDNN and a decrease in mean heart rate at third month and second year control (Table 2) . Mean heart rate was decreased from 83.2 ± 10.7 bpm in the baseline to 78.2 ± 10.1 bpm and 76.4 ± 9.7 bpm in the third month and second year, respectively (Fig. 1A) . SDNN was increased from 61.1 ± 16.6 ms in the baseline to 100.6 ± 28.8 ms and 104.7 ± 29.9 ms in the third month and second year, respectively (Fig. 1B) . The changes in mean heart rate and SDNN between baseline and third month, and between third month and second year were statistically significant (Table 2) .
RESULTS
During 2-year follow-up, 12 major cardiac events were developed in 8 patients. Two patients died (because of heart failure), six patients were hospitalized 10 times due to decompansation of heart failure. In these patients, despite biventricular stimulation caused statistically significant decrease in QRS duration in the third months, diastolic filling time (DFT), left ventricular enddiastolic diameter (LVEDD), LVEF and dP/dt did not show significant changes (Table 3) . Mean heart rate changes in baseline, third month and second year were 88.5 ± 8.2 bpm, 87.2 ± 7.6 bpm and 85.8 ± 7.8 bpm, respectively. Also SDNN in these patients in baseline, third month and second year were 54.6 ± 5.0 ms, 56.6 ± 5.5 ms and 59.0 ± 4.6 ms, respectively. In these patients, the changes in mean heart rate and SDNN were not statisti- DFT, diastolic filling time; LV dP/dt, left ventricular dP/dt; LVEF, left ventricular ejection fraction; SDNN, standard deviation of normal R-R values; LVEDD, left ventricular end-diastolic diameter; mean HR, mean heart rate; P1, p value between baseline and 3 months after CRT; P2, p value between baseline and 2 years afeter CRT; P3, p value between 3 month and 2nd year. Fig. 2 ). In responders (patients without any major cardiac event), SDNN was 62.9 ± 18.3 ms, 113.2 ± 18.2 ms and 117.8 ± 18.9 ms in baseline, third month and second year, respectively. Also, in responders, mean heart rate was decreased from 81.6 ± 11.0 bpm to 75.6 ± 9.3 bpm and 73.8 ± 8.6 bpm in third month and second year respectively (Table 3 , Fig. 2) . In responder patients, biventricular stimulation caused statistically significant decrease in QRS duration, and improvements in DFT, LVEDD, LVEF and dP/dt, indicating reverse remodelling in these patients (Table 3) . At baseline, responders and nonresponders to CRT did not differ in any echocardiographic parameter (Table 4) . Also left ventricular lead position did not differ between responders and nonresponders.
DISCUSSION
The findings of this study show that in symptomatic heart failure patients, CRT improves autonomic functions as quantified by measuring heart rate variability (HRV) and decreases mean heart rate, and these changes usually peaked in a few months after implantation of CRT devices and remained stable years thereafter. The observed improvement is consistent with the improvement of clinical status of the patients and echocardiographic parameters. The absence of changes in HRV and mean heart rate in first three months were seen in nonresponder patients. Those patients also showed no improvement in functional status, no significant change in left ventricular EF, end-diastolic diameter and dP/dt.
Patients with congestive heart failure have autonomic dysfunctions (Hasking et al. 1986; Kienzle et al. 1992; Grassi et al. 1995; Burger and Aronson 2001) . Profound abnormalities in autonomic function, characterized by sympathetic overactivity and parasympathetic withdrawal, exert direct deleterious effects on the heart and contribute to progressive circulatory failure (Grassi et al. 1995; Burger and Aronson 2001) . Increased cardiac sympathetic nerve activity in congestive heart failure is established by determination of cardiac norepinephrine release (Hasking et al. 1986 ). It has been suggested that reduced HRV may be associated with increased norepinephrine levels in patients with severe congestive heart failure (Burger et al. 2001) . Moreover, both reduced total HRV and elevated cardiac norepinephrine spillover have been shown to be independent predictors for the increased mortality in patients with congestive heart failure (Burger et al. 2001 ). Diminished HRV is associated with increased sympathetic and decreased vagal modulation, and these autonomic changes have been associated with an increase in malignant arrhythmias (Lown et al. 1978; Schwartz et al. 1978) . SDNN of HRV is a useful independent prognostic tool in chronic heart failure (Ponikowski et al. 1997; Nolan et al. 1998; Guzzetti et al. 2000) . It has been accepted that an SDNN of more than 100 ms was associated with a relatively good prognosis in patients with congestive heart failure (Ponikowski et al. 1997; Nolan et al. 1998 ). Nolan et al. (1998) reported that the annual mortality rate for the 433 patients with congestive heart failure in SDNN subgroups was 5.5% for > 100 ms, 12.7% for 50 to 100 ms, and 51.4% for < 50 ms. Saxon et al. (1999) reported that permanent biventricular stimulation was associated with a decrease in plasma norepinephrine levels. Accordingly we demonstrated an increase in SDNN, which may be related a reduction of mortality risk from moderate (59.7 ± 17.6 ms) to lower risk (100.3 ± 29.6 ms) in third month, by biventricular pacing in our study population. Although it has been suggested that a reduction in SDNN was a predictor of death due to progressive heart failure, the relationship between HRV and sudden cardiac death, which is another important cause of death in congestive heart failure, has not been well defined (Mortara et al. 1997; Nolan et al. 1998) .
CRT increased overall time-domain HRV, which likely represents changes in both sympathetic and parasympathetic activities. Although reduction in sympathetic nerve activity occurs during abrupt, short-term biventricular pacing in an electrophysiology laboratory setting (Hamdan et al. 2002) , the long-term effects of CRT had no effect on circulating catecholamines (Adamson et al. 2003) . All these findings suggest that benefi-cial autonomic effects of CRT were mostly associated with increased parasympathetic heart rate control. It seems that improvement in SDNN is related to baroreflex gain reseting due to improved stroke volume or changes in affarent nervous signaling from resynchronized ventricular activation (Adamson et al. 2003) .
Measuring of SDNN by 24 hour electrocardiography (ECG) recording may be an important tool to evaluate response to biventricular pacing in congestive heart failure. In one study (Fantoni et al. 2005) , it has been demonstrated that lack of increase in standart deviation of the averages of intrinsic intervals in 288 five-minute segments of a day (SDANN) four weeks after CRT implantation identified patients at highest risk for major cardiovascular events such as death, urgent heart transplantation, direct current (DC) shock for fast ventricular tachyarrhythmias, and hospitalization. Also those patients showed no significant improvements of exercise capacity and no significant change in left ventricular ejection fraction and end-diastolic diameter. Also in another study (Adamson et al. 2004) , continuous HRV was measured as the standard deviation of 5-minute median atrial-atrial intervals (SDAAM). This study demonstrated that SDAAM continuously measured from an implanted cardiac resynchronization device is lower in patients at high mortality and hospitalization risk. SDAAM declined as patient status decompensated. Continuous longterm SDAAM might be a useful tool in the clinical management of patients with chronic heart failure. Similarly, in this study we noticed that SDNN did not increase in non-responder patients in third month and second year Holter monitorings.
We also demonstrated that with CRT mean heart rate was decreased in first three months and this was paralel to increase in HRV. In a study by Fantoni et al. (2005) , it has been suggested that slowing of heart rate was one of the mechanisms to improve cardiac efficiency after CRT. This may have a beneficial effect on diastolic time and on myocardial oxygen demand (Vural et al. 2004) . Therefore, by improving cardiac performance and efficiency, CRT favorably alters the autonomic control of the heart, which may be contributed to the reversal of adverse remodelling demonstrated by echocardiography.
A limitation to our study is the small sample size. We demonstrated a significant increase in SDNN by biventricular pacing, however, a properly designed larger study is required to confirm heart rate variability as a useful tool to evaluate response to biventricular pacing. Another limitation is the use of Holter recordings for HRV analysis. Conventional HRV recording may have limited applicability for repeated measurements in daily practice.
In conclusion, CRT improves cardiac autonomic control, resulting in the increase in SDNN and the decrease in mean heart rate. This was associated with reversal of ventricular remodelling and may contribute to improvements in long-term functional capacity and mortality. Heart rate variability analysis may be a useful tool to evaluate the response to permanent biventricular pacing. 
